Perindopril, thrombosis, inflammation, endothelial dysfunction, and neurohormonal activation trial, a subanalysis of EUROPA - PERTINENT

Description:

The goal of the trial was to evaluate the effect of the ACE inhibitor perindopril compared with placebo on endothelial function in patients with stable coronary artery disease (CAD) enrolled in the EUROPA trial.